Hometown: Litchfield, Maine Undergraduate: Boston University (Biology) Medical school: Harvard Medical School Graduate School: Harvard School of Public Health, M.P.H. Research interests: Costing in health care, value-based health care, quality/outcomes, health care policy, payment reform
Abbott MM, Meara JG. Nasoalveolar molding in cleft care: is it efficacious? Plast Reconstr Surg. 2012: in press.
Abbott MM, Rosen H, Kupfer P, Meara JG. Measuring value at the provider level in the management of cleft lip and palate patients. Ann Plast Surg. 2012; in press.
Kupfer P, Abbott MM, Abramowicz S, Meara JG, Padwa BL. Cost differences between the anterior and posterior approaches to the iliac crest for alveolar bone grafting in patients with cleft lip/palate. J Oral Maxillofac Surg. 2012; 70:685-689.
Abbott MM, Rogers GF, Proctor MR, Busa K, Meara JG. The cost of treating sagittal synostosis in the first year of life: Endoscopically-assisted suturectomy and postoperative helmet therapy vs. open cranial vault remodeling. J Craniofac Surg. 2012; 23:88-93.
Abbott MM, Meara JG. Patient Protection and Affordable Care Act: Implications for pediatric plastic surgery. J Craniofac Surg. 2012;23:1-3.
Abbott MM, Kokorowski PJ, Meara JG. Timeliness of surgical care in children with special health care needs: delayed palate repair for publicly insured and minority children with cleft palate. J Pediatric Surg. 2011;46:1319-1324.
Ganske I, Abbott MM, Meara J. Accountable care organizations: a primer for surgeons. Bull Am Coll Surg. 2011;96:27-35.
Abbott MM, Nguyen V, Meara JG. Surgeons, other providers take the lead on integrating health care services. Bull Am Coll Surg. 2011;96:14-19.
Abbott MM, Alkire BC, Meara JG. The value proposition: utilizing a cost improvement map to improve value for patients with non-syndromic, isolated cleft palate. Plast Reconstr Surg. 2011;127:1650-1658.
Abbott, MM, Meara, JG. A microcosting approach for isolated, unilateral cleft lip care in the first year of life. Plast Reconstr Surg. 2011;127:333-339.
Abbott, MM, Hasserjian RP, Emerick KS. Marginal zone B-cell lymphoma of the infratemporal fossa: A rare case and review. Laryngoscope. 2010;120:2430-2433.
Abbott MM, Meara JG. Value-based cleft lip-cleft palate care: a progress report. Plast Reconstr Surg. 2010;126:1020-1025.
Bacskai BJ, Kajdasz ST, McLellan ME, Games D, Seubert P, Schenk D, Hyman BT. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. J Neurosci. 2002;22:7873-7878.
D’Amore JD, Kajdasz ST, McLellan ME, Bacskai BJ, Stern EA, Hyman BT. In Vivo Multiphoton Imaging of a Transgenic Mouse Model of Alzheimer’s Disease Reveals Marked Thioflavine-S Associated Alterations in Neurite Trajectories. J Neuropathol Exp Neurol. 2003;62:137-145.
Kishida M, McLellan ME, Miranda JA, Callard GV. Estrogen and xenoestrogens upregulate the brain aromatase isoform (P450aromB) and perturb markers of early development in zebrafish (Danio rerio). Comp Biochem Physiol B Biochem Mol Biol. 2001;129:261-268.
Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP, Debnath ML, Holt DP, Wang Y, Hyman BT. Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. J Neuropathol Exp Neurol. 2002;61:797-805.
Mathis CE, Bacskai BJ, Kajdasz ST, McLellan ME, Frosch MP, Hyman BT, Holt DP, Wang Y, Huang GF, Debnath ML, KlunkWE. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett. 2002;12:295-298.
McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. J. Neurosci. 2003;23:2212-2217.
Murphy RA, Sunpath H, Nijhawan A, McLellan ME, Kuritzkes DR. Lopinavir/ritonavir (LPV/r) + two nucleoside analogues as second-line ART in protease-inhibitor naïve adults in South Africa: outcomes and adverse effects. As presented at The 15th Annual Conference on Retroviruses and Opportunistic Infections (CROI) Boston, MA: Feb. 3-5, 2008.